| Citation: |
CAO Wei, GUO Kai, WO Meihong, SU Beibei, SUN Yu, YING Changjiang. Correlation between atherogenic index of plasma and diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 125-129. DOI: 10.7619/jcmp.20220275
|
To explore the correlation between atherogenic index of plasma(AIP) and diabetic retinopathy(DR).
A total of 445 patients with type 2 diabetes hospitalized in the Affiliated Hospital of Xuzhou Medical University were selected as study objects. According to DR diagnosis and staging criteria, the patients were divided into non-DR group (NDR group, n=188), nonproliferative group (NPDR group, n=134) and proliferative group (PDR group, n=123). The general information of patients and main biochemical indicators were collected. The general data and main biochemical indicators of patients in each group were compared, and AIP was calculated. The risk factors of DR were analyzed by Logistic regression, the correlations of AIP with risk factors were analyzed by Spearman correlation, and receiver operating characteristic (ROC) curve was used to analyze the value of AIP in screening DR.
Age in the PDR group was older, duration of diabetes in the PDR group was longer, the level of fasting blood glucose(FBG), glycosylated hemoglobin (HbA1c), low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and AIP in the PDR group were significantly higher, and the level of estimated glomerular filtration (eGFR) were lower than those in the NDR group and NPDR group(P < 0.05). Logistic regression analysis showed that age, duration of diabetes, HbA1c, LDL-C, eGFR and AIP were independent influencing factors for DR in T2DM patients. The area under the curve of AIP in predicting DR in T2DM patients was 0.745 (95%CI, 0.700 to 0.791). The threshold of AIP for DR screening was 0.186, the sensitivity was 74.3%, and the specificity was 64.4%.
AIP may be a reliable new indicator for DR screening in T2DM patients.
| [1] |
LI Y Z, TENG D, SHI X G, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997.
|
| [2] |
TEO Z L, THAM Y C, YU M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis[J]. Ophthalmology, 2021, 128(11): 1580-1591. doi: 10.1016/j.ophtha.2021.04.027
|
| [3] |
DOBIÁSOVÁ M, RASLOVÁK, RAUCHOVÁH, et al. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction[J]. Physiol Res, 2001, 50(1): 1-8.
|
| [4] |
ZHOU Y P, SHANG X L. Usefulness of atherogenic index of plasma for estimating reduced eGFR risk: insights from the national health and nutrition examination survey[J]. Postgrad Med, 2021, 133(3): 278-285. doi: 10.1080/00325481.2020.1838138
|
| [5] |
HERNÁNDEZ J L, OLMOS J M, PARIENTE E, et al. The atherogenic index of plasma is related to a degraded bone microarchitecture assessed by the trabecular bone score in postmenopausal women: the Camargo Cohort Study[J]. Maturitas, 2021, 148: 1-6. doi: 10.1016/j.maturitas.2021.03.008
|
| [6] |
FLAXEL C J, ADELMAN R A, BAILEY S T, et al. Diabetic retinopathy preferred practice pattern[J]. Ophthalmology, 2020, 127(1): P66-P145. doi: 10.1016/j.ophtha.2019.09.025
|
| [7] |
ISMAIL-BEIGI F, CRAVEN T, BANERJI M A, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial[J]. Lancet, 2010, 376(9739): 419-430. doi: 10.1016/S0140-6736(10)60576-4
|
| [8] |
ONAT A, CAN G, KAYA H S, et al. "Atherogenic index of plasma" (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events[J]. J Clin Lipidol, 2010, 4(2): 89-98. doi: 10.1016/j.jacl.2010.02.005
|
| [9] |
NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) EXPERT PANEL ON DETECTION E. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report[J]. Circulation, 2002, 106(25): 3143-3421. doi: 10.1161/circ.106.25.3143
|
| [10] |
FU L Y, ZHOU Y, SUN J X, et al. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus[J]. Cardiovasc Diabetol, 2021, 20(1): 201. doi: 10.1186/s12933-021-01393-5
|
| [11] |
张倩倩, 时涵远, 李馨航, 等. 甘油三酯-葡萄糖指数和血浆致动脉硬化指数评价冠心病的临床价值[J]. 天津医科大学学报, 2022, 28(1): 73-76. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYK202201016.htm
|
| [12] |
QIN Z, ZHOU K, LI Y P, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China[J]. Cardiovasc Diabetol, 2020, 19(1): 23. doi: 10.1186/s12933-020-0989-8
|
| [13] |
赵洁, 李淑英, 张英, 等. 中青年和老年冠心病患者LDL不同亚型与AIP的相关性分析[J]. 天津医药, 2021, 49(1): 54-58. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYZ202101013.htm
|
| [14] |
AKBAS E M, TIMUROGLU A, OZCICEK A, et al. Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus[J]. Int J Clin Exp Med, 2014, 7(12): 5737-5743.
|
| [15] |
WONG T Y, CHEUNG N, TAY W T, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study[J]. Ophthalmology, 2008, 115(11): 1869-1875. doi: 10.1016/j.ophtha.2008.05.014
|
| [16] |
RELHAN N, FLYNN H W Jr. The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema[J]. Curr Opin Ophthalmol, 2017, 28(3): 205-212. doi: 10.1097/ICU.0000000000000362
|
| [17] |
SRINIVASAN S, RAMAN R, KULOTHUNGAN V, et al. Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-Ⅱ[J]. Clin Exp Ophthalmol, 2017, 45(9): 894-900. doi: 10.1111/ceo.12990
|
| [18] |
EBELING P, KOIVISTO V A. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland[J]. Acta Diabetol, 1997, 34(1): 33-38. doi: 10.1007/s005920050062
|
| [19] |
KANTER J E, HSU C C, BORNFELDT K E. Monocytes and macrophages as protagonists in vascular complications of diabetes[J]. Front Cardiovasc Med, 2020, 7: 10. doi: 10.3389/fcvm.2020.00010
|
| [20] |
CANPOLAT A G, EMRAL R, KESKIN Ç, et al. Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type Ⅱdiabetes mellitus[J]. Biomark Med, 2019, 13(11): 907-915. doi: 10.2217/bmm-2018-0451
|
| [21] |
ROLIN J, MAGHAZACHI A A. Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis[J]. J Leukoc Biol, 2014, 95(4): 575-585. doi: 10.1189/jlb.1113571
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: